HK1203970A1 - New actinomycete integrative and conjugative element from actinoplanes sp.se50/110 as plasmid for genetic transformation of related actinobacteria se50/110 - Google Patents

New actinomycete integrative and conjugative element from actinoplanes sp.se50/110 as plasmid for genetic transformation of related actinobacteria se50/110

Info

Publication number
HK1203970A1
HK1203970A1 HK15104333.1A HK15104333A HK1203970A1 HK 1203970 A1 HK1203970 A1 HK 1203970A1 HK 15104333 A HK15104333 A HK 15104333A HK 1203970 A1 HK1203970 A1 HK 1203970A1
Authority
HK
Hong Kong
Prior art keywords
actinoplanes
plasmid
genetic transformation
conjugative element
actinobacteria
Prior art date
Application number
HK15104333.1A
Other languages
English (en)
Chinese (zh)
Inventor
Andreas Klein
Klaus Selber
Hermann Wehlmann
Winfried Rosen
Alfred Phler
Patrick Schwientek
Jrn Kalinowski
Udo Wehmeier
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of HK1203970A1 publication Critical patent/HK1203970A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/365—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinoplanes (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK15104333.1A 2011-12-08 2015-05-07 New actinomycete integrative and conjugative element from actinoplanes sp.se50/110 as plasmid for genetic transformation of related actinobacteria se50/110 HK1203970A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11192618 2011-12-08
PCT/EP2012/074366 WO2013083566A1 (en) 2011-12-08 2012-12-04 New actinomycete integrative and conjugative element from actinoplanes sp. se50/110 as plasmid for genetic transformation of related actinobacteria

Publications (1)

Publication Number Publication Date
HK1203970A1 true HK1203970A1 (en) 2015-11-06

Family

ID=47278320

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15104333.1A HK1203970A1 (en) 2011-12-08 2015-05-07 New actinomycete integrative and conjugative element from actinoplanes sp.se50/110 as plasmid for genetic transformation of related actinobacteria se50/110

Country Status (12)

Country Link
US (2) US9217154B2 (xx)
EP (1) EP2788373B1 (xx)
JP (1) JP2015501641A (xx)
KR (1) KR20140109922A (xx)
CN (1) CN104144942A (xx)
AR (1) AR089117A1 (xx)
CA (1) CA2858259A1 (xx)
ES (1) ES2718331T3 (xx)
HK (1) HK1203970A1 (xx)
IL (1) IL232587A (xx)
IN (1) IN2014CN04155A (xx)
WO (1) WO2013083566A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2014CN04155A (xx) 2011-12-08 2015-07-17 Bayer Ip Gmbh
CN112592878B (zh) * 2020-12-25 2022-08-26 上海交通大学 增强正调控蛋白基因表达以提高阿卡波糖发酵水平的方法
CN112522174B (zh) * 2020-12-25 2022-08-09 上海交通大学 一种敲除负调控蛋白基因以提高阿卡波糖发酵水平的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2064092C2 (de) 1970-12-28 1983-06-01 Bayer Ag, 5090 Leverkusen Inhibitoren für Glykosidhydrolasen aus Actinomyceten
DE2209834C3 (de) 1972-03-01 1978-04-20 Bayer Ag, 5090 Leverkusen Herstellung von Saccharase-Inhibitoren
DE2347782C3 (de) 1973-09-22 1979-10-11 Bayer Ag, 5090 Leverkusen Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US4062950A (en) 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
EP0796915A3 (de) * 1996-03-22 1999-04-14 Bayer Ag Verfahren zur Herstellung sowie zur Verwendung von Acarviosyl-Transferase bei der Umwandlung von Acarbose-Homologen in Acarbose, zur Herstellung von Acarbose-Homologen
AU2008282876A1 (en) * 2007-07-27 2009-02-05 Wyeth Vectors and methods for cloning gene clusters or portions thereof
TW201217533A (en) * 2010-08-04 2012-05-01 Bayer Pharma AG Genomics of actinoplanes utahensis
IN2014CN04155A (xx) 2011-12-08 2015-07-17 Bayer Ip Gmbh

Also Published As

Publication number Publication date
US9217154B2 (en) 2015-12-22
JP2015501641A (ja) 2015-01-19
CN104144942A (zh) 2014-11-12
CA2858259A1 (en) 2013-06-13
IL232587A0 (en) 2014-06-30
WO2013083566A1 (en) 2013-06-13
ES2718331T3 (es) 2019-07-01
KR20140109922A (ko) 2014-09-16
AR089117A1 (es) 2014-07-30
EP2788373B1 (en) 2019-01-23
EP2788373A1 (en) 2014-10-15
US9562249B2 (en) 2017-02-07
IN2014CN04155A (xx) 2015-07-17
US20140349346A1 (en) 2014-11-27
IL232587A (en) 2017-08-31
US20160130622A1 (en) 2016-05-12

Similar Documents

Publication Publication Date Title
IL281295A (en) Preparations and methods for inhibiting expression of the ALAS1 gene
HK1197056A1 (zh) 作為 抑制劑的氮雜環丁烷基苯基、吡啶基或吡嗪基甲酰胺衍生物
EP2890780B8 (en) Methods and compositions for treatment of a genetic condition
EP2855680B8 (en) Compositions and methods for silencing gene expression
HK1244033A1 (zh) 用於細菌的多順反子表達系統
IL228328B (en) Aav vectors without capsid, preparations and methods for vector preparation and gene transfer
EP3495485A3 (en) Exon skipping compositions for treating muscular dystrophy
WO2014153220A3 (en) Exon skipping compositions for treating muscular dystrophy
SG11201403276TA (en) Modified microorganisms and methods of making butadiene using same
EP2723756A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING THE EXPRESSION OF APOLIPOPROTEIN C-III (APOC3) GENES
IN2014DN08481A (xx)
ZA201400563B (en) Axmi270 toxin gene and methods for its use
EP2710119A4 (en) COMPOSITION AND METHODS FOR INHIBITION OF JAMM PROTEINS
HUE044065T2 (hu) Végbetét és mágnesrúd katódporlasztásos rendszerhez
ZA201308585B (en) Methods for regulating sirtuin gene expression
EP2723861A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING HEPCIDINE ANTIMICROBIAL PEPTIDE (HAMP) OR THE ASSOCIATED GENE EXPRESSION
HK1201560A1 (en) Reduced genome bacteria with improved genetic stability
HK1197265A1 (en) Method for highly expressing recombinant protein of engineering bacteria and use thereof
EP2931746A4 (en) METHOD AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF CKAP5 BY DOUBLE-STRUCTURED RNA
HK1203970A1 (en) New actinomycete integrative and conjugative element from actinoplanes sp.se50/110 as plasmid for genetic transformation of related actinobacteria se50/110
HK1197238A1 (en) 5 - benzylaminomethyl - 6 - aminopyrazolo [3, 4 -b] pyridine derivatives as cholesteryl ester -transfer protein (cetp) inhibitors useful for the treatment of atherosclerosis (cetp) 5- -6-[34-b]
EP2792744A4 (en) GENE TARGETING VECTOR AND METHOD OF USE
EP3383998A4 (en) MODULAR BIOREACTOR FOR CULTIVATION OF BIOPAPIER TISSUES
ZA201307057B (en) Proteins for biocontrol of plant pathogenic fungi
AU2013201585B9 (en) Methods for treating HCV